Promoter Methylation and Phosphorylation Status of PTEN in Taiwanese Breast Cancer

被引：0
作者：
Hou, M-F
Chen, P-H
Yeh, Y-T
机构：
[1] Kaohsiung Med Univ, Kaohsiung, Taiwan
[2] Fooyin Univ, Kaohsiung, Taiwan
来源：
CANCER RESEARCH | 2009年 / 69卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：726S / 727S
页数：2
相关论文
共 50 条
  • [41] The prognostic effect of PTEN expression status in colorectal cancer development and evaluation of factors affecting it: miR-21 and promoter methylation
    Yazdani, Yaghoub
    Farazmandfar, Touraj
    Azadeh, Hossein
    Zekavatian, Zeinab
    JOURNAL OF BIOMEDICAL SCIENCE, 2016, 23
  • [42] The prognostic effect of PTEN expression status in colorectal cancer development and evaluation of factors affecting it: miR-21 and promoter methylation
    Yaghoub Yazdani
    Touraj Farazmandfar
    Hossein Azadeh
    Zeinab Zekavatian
    Journal of Biomedical Science, 23
  • [43] The Promoter Methylation Status and mRNA Expression Levels of CTCF and SIRT6 in Sporadic Breast Cancer
    Wang, Da
    Li, Changlong
    Zhang, Xuemei
    DNA AND CELL BIOLOGY, 2014, 33 (09) : 581 - 590
  • [44] Methylation status of WIF-1 promoter region in breast cancer cell lines and tumour tissues
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 138 - 138
  • [45] The correlation between Twist 1 and 2 promoter methylation status and clinicopathologic characteristics of patients with breast cancer
    Fattahi, Maryam
    Sheervalilou, Roghayeh
    Hoseinpour, Nina
    Valiloo, Mohammad
    Pedram, Negar
    Montazeri, Vahid
    Nejati, Kazm
    Abtin, Maryam
    Seif, Farhad
    Alivand, Mohammad-Reza
    GENE REPORTS, 2020, 20
  • [46] Methylation status of RARbeta2 promoter in esophageal cancer
    Graziani, D
    Ghisini, R
    Romagnoli, S
    Maggioni, M
    Sirchia, S
    Sacchi, N
    Bonavina, L
    Peracchia, A
    Bosari, S
    Coggi, G
    LABORATORY INVESTIGATION, 2002, 82 (01) : 128A - 128A
  • [47] Expression of breast cancer resistance protein depends on the methylation status of its promoter region in lung cancer cells.
    Tsukamoto, K
    Kamikatahira, M
    Sado, S
    Yanagihara, K
    Kishino, T
    Oka, M
    Kohno, S
    Murata, I
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 250 - 250
  • [48] Methylation status of RARbeta2 promoter in esophageal cancer
    Graziani, D
    Ghisini, R
    Romagnoli, S
    Maggioni, M
    Sirchia, S
    Sacchi, N
    Bonavina, L
    Peracchia, A
    Bosari, S
    Coggi, G
    MODERN PATHOLOGY, 2002, 15 (01) : 128A - 128A
  • [49] BRCA1 Promoter Methylation Status in Ovarian Cancer
    Nikbakht, Mahdi
    Shabanizadeh, Ahmad
    Salehi, Mansour
    Talebi, Ardeshir
    Arababadi, Mohammad Kazemi
    Dahim, Hajar
    Kennedy, Derek
    LABMEDICINE, 2012, 43 (04): : 122 - 124
  • [50] Promoter methylation status of the FHIT gene and Fhit expression: Association with HER2/neu status in breast cancer patients
    Jeong, Young Ju
    Jeong, Hye Yeon
    Lee, Sang Min
    Bong, Jin Gu
    Park, Sung Hwan
    Oh, Hoon Kyu
    ONCOLOGY REPORTS, 2013, 30 (05) : 2270 - 2278
12345